TANG PRIZE/Tang Prize honors scientists for work to combat diabetes, obesity
06/19/2024 05:17 PM
Three scientists were awarded the 2024 Tang Prize in Biopharmaceutical Science for discovering the Glucagon-like peptide-1 (7-37) (GLP-1 (7-37)) stimulates insulin secretion and can be used in medication combating diabetes and obesity, the Tang Prize Selection Committee announced Wednesday in Taipei.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in TANG PRIZE
U.S. research funding cuts hurt scientific progress: Tang Prize laureatesThe 2026 Tang Prize laureates in Biopharmaceutical Science warned Saturday that cuts to U.S. government research funding could slow scientific progress and reduce opportunities for young researchers, with potentially long-term consequences for the scientific workforce.09/19/2026 07:39 PM
Find pivotal moments that shape history: Tang Prize Sinology laureateGe Zhaoguang (葛兆光) used his platform as the 2026 Tang Prize laureate in Sinology on Saturday to encourage historians to broaden their perspective and focus on identifying pivotal moments that shape history's course.09/19/2026 07:02 PM
Ozone recovery a rare success story: Tang Prize laureate Susan SolomonThe recovery of the Antarctic ozone layer represents a rare example of science and international policy successfully addressing a global environmental threat, said Susan Solomon, whose research on chlorofluorocarbons (CFCs) earned her the 2026 Tang Prize in Sustainable Development.09/19/2026 05:25 PM
Latest
- Society
Dead passenger found on bus days after boarding; operator fined
09/28/2026 01:53 PM - Sports
High jumper Fu Chao-hsuan finds his stride with Asian Games gold
09/28/2026 12:56 PM - Politics
DPP at 40: Founders reflect on risk, rise, reckoning
09/28/2026 11:10 AM - Society
Heat warnings issued Monday across Taiwan
09/28/2026 10:36 AM - Business
Taiwan headline news
09/28/2026 10:29 AM


